Torrent Pharma Valsartan Recall [US]

US/Silver Spring: Torrent Pharmaceuticals Limited, an Ahmedabad, Gujarat establishment, recalls all unexpired batch/lots of Valsartan/Amlodipine/HCTZ, Valsartan/Amlodipine and Valsartan Tablets due to suspected N-Nitrosodimethylamine (“NDMA”) contamination and consequential risks of Carcinogen damage and Cancer, all serious health hazards.

FDA: http://ht.ly/Qhee30lylJS

Direct link: https://www.fda.gov/Safety/Recalls/ucm617821.htm

Additional information:
The US Food and Drug Administration (“FDA”) reports the following Valsartan Tablets are subject to this recall:

• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2D025 and an expiration date of November 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2D026 and an expiration date of November 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2E001 and an expiration date of January 2020
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2E002 and an expiration date of January 2020
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2E003 and an expiration date of January 2020
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2E004 and an expiration date of January 2020
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2E005 and an expiration date of January 2020
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/160mg/25mg, 30 Tablets, sold with an NDC designation of 13668-328-30, a batch/lot of BBX9D004 and an expiration date of November 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/160mg/25mg, 30 Tablets, sold with an NDC designation of 13668-328-30, a batch/lot of BBX9E001 and an expiration date of January 2020
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 5mg/160mg/12.5mg, 30 Tablets, sold with an NDC designation of 13668-326-30, a batch/lot of BBY1E001 and an expiration date of December -2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 5mg/160mg/12.5mg, 30 Tablets, sold with an NDC designation of 13668-326-30, a batch/lot of BBY1E003 and an expiration date of March 2020
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/160mg/12.5mg, 30 Tablets, sold with an NDC designation of 13668-327-30, a batch/lot of BBY2E001 and an expiration date of March 2020
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 5mg/160mg/25mg, 30 Tablets, sold with an NDC designation of 13668-329-30, a batch/lot of BBY4D004 and an expiration date of November 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 5mg/160mg/25mg, 30 Tablets, sold with an NDC designation of 13668-329-30, a batch/lot of BBY4E001 and an expiration date of January 2020
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 5mg/160mg/25mg, 30 Tablets, sold with an NDC designation of 13668-329-30, a batch/lot of BBY4E001 and an expiration date of January 2020
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2D003 and an expiration date of March 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2D004 and an expiration date of March 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2D005 and an expiration date of March 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2D006 and an expiration date of March 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2D007 and an expiration date of March 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2D008 and an expiration date of March 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2D015 and an expiration date of October 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2D016 and an expiration date of October 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2D017 and an expiration date of October 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2D018 and an expiration date of October 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2D019 and an expiration date of October 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2D020 and an expiration date of October 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2D021 and an expiration date of October 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2D022 and an expiration date of October 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2D023 and an expiration date of October 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2D024 and an expiration date of November 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/160mg/25mg, 30 Tablets, sold with an NDC designation of 13668-328-30, a batch/lot of BBX9D001 and an expiration date of February 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 5mg/160mg/12.5mg, 30 Tablets, sold with an NDC designation of 13668-326-30, a batch/lot of BBY1C002 and an expiration date of September 2018
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 5mg/160mg/12.5mg, 30 Tablets, sold with an NDC designation of 13668-326-30, a batch/lot of BBY1E002 and an expiration date of March 2020
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/160mg/12.5mg, 30 Tablets, sold with an NDC designation of 13668-327-30, a batch/lot of BBY2D001 and an expiration date of February 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/160mg/12.5mg, 30 Tablets, sold with an NDC designation of 13668-327-30, a batch/lot of BBY2D002 and an expiration date of November 2019
• Amlodipine and Valsartan Tablets 5 mg/160 mg, USP, 30 Tablets, sold with an NDC designation of 13668-207-30, a batch/lot of BV53D004 and an expiration date of October 2019
• Amlodipine and Valsartan Tablets 10 mg/160 mg, USP, 30 Tablets, sold with an NDC designation of 13668-206-30, a batch/lot of BV65D002 and an expiration date of October 2019
• Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-204-30, a batch/lot of BV77D013 and an expiration date of October 2019
• Amlodipine and Valsartan Tablets 5 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-205-30, a batch/lot of BV84D010 and an expiration date of October 2019
• Amlodipine and Valsartan Tablets 5 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-205-30, a batch/lot of BV84E001 and an expiration date of December 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2D001 and an expiration date of December 2018
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2D002 and an expiration date of December 2018
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2D009 and an expiration date of March 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2D010 and an expiration date of April 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2D011 and an expiration date of April 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2D012 and an expiration date of May 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2D013 and an expiration date of May 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2D014 and an expiration date of August 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/160mg/25mg, 30 Tablets, sold with an NDC designation of 13668-328-30, a batch/lot of BBX9D002 and an expiration date of March 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/160mg/25mg, 30 Tablets, sold with an NDC designation of 13668-328-30, a batch/lot of BBX9D003 and an expiration date of July 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 5mg/160mg/12.5mg, 30 Tablets, sold with an NDC designation of 13668-326-30, a batch/lot of BBY1D001 and an expiration date of May 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 5mg/160mg/25mg, 30 Tablets, sold with an NDC designation of 13668-329-30, a batch/lot of BBY4D001 and an expiration date of April 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 5mg/160mg/25mg, 30 Tablets, sold with an NDC designation of 13668-329-30, a batch/lot of BBY4D002 and an expiration date of April 2019
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 5mg/160mg/25mg, 30 Tablets, sold with an NDC designation of 13668-329-30, a batch/lot of BBY4D003 and an expiration date of June 2019
• Valsartan Tablets, USP, 80 mg, 90 Tablets, sold with an NDC designation of 13668-068-90, a batch/lot of BV46C007 and an expiration date of September 2018
• Valsartan Tablets, USP, 80 mg, 90 Tablets, sold with an NDC designation of 13668-068-90, a batch/lot of BV46C008 and an expiration date of October 2018
• Valsartan Tablets, USP, 80 mg, 90 Tablets, sold with an NDC designation of 13668-068-90, a batch/lot of BV46C009 and an expiration date of October 2018
• Valsartan Tablets, USP, 80 mg, 90 Tablets, sold with an NDC designation of 13668-068-90, a batch/lot of BV46C010 and an expiration date of October 2018
• Valsartan Tablets, USP, 80 mg, 90 Tablets, sold with an NDC designation of 13668-068-90, a batch/lot of BV46C011 and an expiration date of November 2018
• Valsartan Tablets, USP, 80 mg, 90 Tablets, sold with an NDC designation of 13668-068-90, a batch/lot of BV46C012 and an expiration date of November 2018
• Valsartan Tablets, USP,160 mg, 90 Tablets, sold with an NDC designation of 13668-069-90, a batch/lot of BV47C005 and an expiration date of September 2018
• Valsartan Tablets, USP, 160 mg, 90 Tablets, sold with an NDC designation of 13668-069-90, a batch/lot of BV47C006 and an expiration date of September 2018
• Valsartan Tablets, USP, 160 mg, 90 Tablets, sold with an NDC designation of 13668-069-90, a batch/lot of BV47D001 and an expiration date of December 2018
• Valsartan Tablets, USP, 320 mg, 90 Tablets, sold with an NDC designation of 13668-070-90, a batch/lot of BV48D001 and an expiration date of December 2018
• Valsartan Tablets, USP, 320 mg, 90 Tablets, sold with an NDC designation of 13668-070-90, a batch/lot of BV48D002 and an expiration date of December 2018
• Amlodipine and Valsartan Tablets 5 mg/160 mg, USP, 30 Tablets, sold with an NDC designation of 13668-207-30, a batch/lot of BV53C006 and an expiration date of November 2018
• Amlodipine and Valsartan Tablets 5 mg/160 mg, USP, 30 Tablets, sold with an NDC designation of 13668-207-30, a batch/lot of BV53D001 and an expiration date of February 2019
• Amlodipine and Valsartan Tablets 5 mg/160 mg, USP, 30 Tablets, sold with an NDC designation of 13668-207-30, a batch/lot of BV53D002 and an expiration date of February 2019
• Amlodipine and Valsartan Tablets 5 mg/160 mg, USP, 30 Tablets, sold with an NDC designation of 13668-207-30, a batch/lot of BV53D003 and an expiration date of September 2019
• Amlodipine and Valsartan Tablets 10 mg/160 mg, USP, 30 Tablets, sold with an NDC designation of 13668-206-30, a batch/lot of BV65C002 and an expiration date of September 2018
• Amlodipine and Valsartan Tablets 10 mg/160 mg, USP, 30 Tablets, sold with an NDC designation of 13668-206-30, a batch/lot of BV65C003 and an expiration date of October 2018
• Amlodipine and Valsartan Tablets 10 mg/160 mg, USP, 30 Tablets, sold with an NDC designation of 13668-206-30, a batch/lot of BV65C004 and an expiration date of November 2018
• Amlodipine and Valsartan Tablets 10 mg/160 mg, USP, 30 Tablets, sold with an NDC designation of 13668-206-30, a batch/lot of BV65D001 and an expiration date of August 2019
• Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-204-30, a batch/lot of BV77C011 and an expiration date of October 2018
• Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-204-30, a batch/lot of BV77D001 and an expiration date of February 2019
• Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-204-30, a batch/lot of BV77D002 and an expiration date of February 2019
• Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-204-30, a batch/lot of BV77D003 and an expiration date of February 2019
• Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-204-30, a batch/lot of BV77D004 and an expiration date of February 2019
• Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-204-30, a batch/lot of BV77D005 and an expiration date of February 2019
• Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-204-30, a batch/lot of BV77D006 and an expiration date of February 2019
• Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-204-30, a batch/lot of BV77D007 and an expiration date of February 2019
• Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-204-30, a batch/lot of BV77D008 and an expiration date of May 2019
• Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-204-30, a batch/lot of BV77D009 and an expiration date of August 2019
• Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-204-30, a batch/lot of BV77D010 and an expiration date of September 2019
• Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-204-30, a batch/lot of BV77D011 and an expiration date of September 2019
• Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-204-30, a batch/lot of BV77D012 and an expiration date of September 2019
• Amlodipine and Valsartan Tablets 5 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-205-30, a batch/lot of BV84C011 and an expiration date of October 2018
• Amlodipine and Valsartan Tablets 5 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-205-30, a batch/lot of BV84D001 and an expiration date of January 2019
• Amlodipine and Valsartan Tablets 5 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-205-30, a batch/lot of BV84D002 and an expiration date of January 2019
• Amlodipine and Valsartan Tablets 5 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-205-30, a batch/lot of BV84D005 and an expiration date of February 2019
• Amlodipine and Valsartan Tablets 5 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-205-30, a batch/lot of BV84D006 and an expiration date of February 2019
• Amlodipine and Valsartan Tablets 5 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-205-30, a batch/lot of BV84D007 and an expiration date of February 2019
• Amlodipine and Valsartan Tablets 5 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-205-30, a batch/lot of BV84D008 and an expiration date of May 2019
• Amlodipine and Valsartan Tablets 5 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-205-30, a batch/lot of BV84D009 and an expiration date of May 2019
• Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-204-30, a batch/lot of BV77C009 and an expiration date of August 2018
• Amlodipine and Valsartan Tablets 10 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-204-30, a batch/lot of BV77C010 and an expiration date of August 2018
• Amlodipine and Valsartan Tablets 5 mg/160 mg, USP, 30 Tablets, sold with an NDC designation of 13668-207-30, a batch/lot of BV53C004 and an expiration date of August 2018
• Amlodipine and Valsartan Tablets 5 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-207-30, a batch/lot of BV53C005 and an expiration date of August 2018
• Amlodipine and Valsartan Tablets 5 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-205-30, a batch/lot of BV84C006 and an expiration date of August 2018
• Amlodipine and Valsartan Tablets 5 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-205-30, a batch/lot of BV84C007 and an expiration date of August 2018
• Amlodipine and Valsartan Tablets 5 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-205-30, a batch/lot of BV84C008 and an expiration date of August 2018
• Amlodipine and Valsartan Tablets 5 mg/320 mg, USP, 30 Tablets, sold with an NDC designation of 13668-205-30, a batch/lot of BV84C009 and an expiration date of August 2018
• Amlodipine, Valsartan and Hydrochlorothiazide Tablets, USP 10mg/320mg/25mg, 30 Tablets, sold with an NDC designation of 13668-325-30, a batch/lot of BBX2C007 and an expiration date of August 2018
• Valsartan Tablets USP, 160 mg, 90 Tablets, sold with an NDC designation of 13668-069-90, a batch/lot of BV47C003 and an expiration date of August 2018
• Valsartan Tablets USP, 160 mg, 90 Tablets, sold with an NDC designation of 13668-069-90, a batch/lot of BV47C004 and an expiration date of August 2018
• Valsartan Tablets USP, 80 mg, 90 Tablets, sold with an NDC designation of 13668-068-90, a batch/lot of BV46C003 and an expiration date of August 2018
• Valsartan Tablets USP, 80 mg, 90 Tablets, sold with an NDC designation of 13668-068-90, a batch/lot of BV46C006 and an expiration date of August 2018

==> No barcodes, UPCs, item numbers or other identification numbers were listed with this recall notification.

Valsartan USP, is a prescription medication used to treat high blood pressure and congestive heart failure.

According to the FDA, Torrent is arranging for return of all recalled products to Qualanex.

Consumers should contact their doctor for further guidance and potential change of treatment before they stop taking this product. Pharmacies and healthcare facilities that have product being recalled should stop using and dispensing the product immediately.

==> Never stop taking your prescription medications, including Valsartan, without the knowledge and approval of your personal physician or other MD familiar with your medical history, current health status and other drugs, medications and supplements you may be consuming. Failure to do so, may result in a serious drug interaction, side effect, complication, personal injury and/or death.

If you believe you have purchased or have in your possession any of the recalled drugs, please do not consume them directly nor use them as an ingredient in another treatment. Instead, return the drugs to the pharmacy or other outlet where you purchased it for a full refund or exchange.

==> To see other recalls and notifications caused by contaminated, adulterated or mislabeled Valsartan, please search for “Valsartan” using the Search Box at the top of this page.

==> To see other recalls and notifications caused by suspected Carcinogenic contamination, please search for “Cancer” or more generically, “fragment” using the Search Box at the top of this page.

==> To see other recalls and notifications for products manufactured, marketed and/or sold by Torrent Pharmaceuticals, Inc., please search for “Torrent” using the Search Box at the top of this page.

==> To see other recalls and notifications for products manufactured, marketed and/or distributed by Qualanex, LLC, please search for “Qualanex” using the Search Box at the top of this page.

___________________________________________________________

More information about this recall:
Recalls Direct RIN: 10555-2018
Want to read more about this recall?
==> Please click on the links above to visit the originating site.
Want to read more about other recalls?
==> Please click on the links below.

General information:
More recalls? Back to the main Recalls Direct page:
==> http://www.RecallsDirect.com/
About the Recalls Direct service:
==> http://wp.me/P2bVty-2
Visit the Living Safely site:
==> http://www.LivingSafely.org/
Report an unsafe food or drug you purchased in the US [external: new window opens]:
==> http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm095859.htm
Search for a recalled food or drug on the US FDA Web archive [external: new window opens]:
==> http://www.fda.gov/Safety/Recalls/ArchiveRecalls/default.htm

We welcome your feedback:
Want to e-mail or share this recall?
==> Simply use the “Share this” options below.
Is this recall relevant to you? Please let us know!
==> Click on the “Like” button below.
E. & O. E.

___________________________________________________________